African Perspectives on Genetically Modified Crops

The use of genetically modified organisms (GMOs) to boost agricultural productivity is often touted in Washington policy circles as a potentially powerful tool for boosting agricultural productivity and reducing food insecurity in Africa. That confidence has not been shared by African governments, many of whom remain wary of transgenic technologies. The Green Revolution in agriculture passed largely unnoticed in Africa. While in Asia and Latin America the introduction of improved crop varieties and the application of scientific farming methods enabled food production to outstrip population growth, in Africa agricultural productivity actually declined. On a per capita basis, Africa’s farms produced almost a fifth less in 2005 than they did in 1970.1 Africa currently imports a quarter of its food, even though 70 percent of its people are engaged in agriculture.

Spotlight

Medical Innovations Group

Medical Innovations Group designs and manufactures medical equipment for a diverse range of markets - from Hospitals and Emergency Services to the Armed Forces. All products are developed under tight quality-controlled conditions and have undergone extensive testing and trials. As a result, they meet the highest possible quality and regulatory standards.

OTHER WHITEPAPERS
news image

Using Clinical Breakpoints to Improve Antimicrobial Resistance Detection

whitePaper | December 13, 2022

Define the ongoing pandemic of antimicrobial resistance. Discuss how we can address the ongoing pandemicin the Clinical Microbiology Laboratory

Read More
news image

WHO considerations on Regulatory Convergence of Cell and Gene Therapy Products

whitePaper | December 16, 2021

Use of cells, tissues, and gene therapy products for the treatment of diseases or 72 physiological conditions has become of wide interest due to their potential to address serious 73 unmet medical needs.

Read More
news image

Cell and Gene Therapy Clinical Trials

whitePaper | November 8, 2022

Using experienced-based best practices and documented tools, ICON has conducted over 63 CGT trials across multiple therapeutic areas from haematology-oncology torare and orphan diseases.

Read More
news image

A REVIEW OF THE RESEARCH TRENDS AND DEVELOPMENTS

whitePaper | May 9, 2022

In the last decade, there has been an encouraging shift in research, clinical development, and commercial activity to exploit the many biological roles of ribonucleic acid (RNA) for use in medicine.

Read More
news image

Biosimilars in the United States 2023–2027

whitePaper | January 31, 2023

The first biosimilar approved under the abbreviated pathway established by the Biologics Price Competition and Innovation Act launched in the U.S. in 2015.

Read More
news image

Recruitment, Retention & Diversity: The Evolution of Patient Engagement in Clinical Trials

whitePaper | January 23, 2023

Recruitment, retention, and diversity are critical elements of clinical trials that, if insufficient, can jeopardize successful trial completion.

Read More

Spotlight

Medical Innovations Group

Medical Innovations Group designs and manufactures medical equipment for a diverse range of markets - from Hospitals and Emergency Services to the Armed Forces. All products are developed under tight quality-controlled conditions and have undergone extensive testing and trials. As a result, they meet the highest possible quality and regulatory standards.

Events